Atlas Trials

177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT03874884 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03874884
Sponsor
Peter MacCallum Cancer Centre, Australia
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Start date
2019-07-09
Primary completion
2025-05-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.